baber/WOPTO huggingface dataset:
Patent CA-2580283-A1 (CA)
Inventor: DAVEY ROBERT JOHN
IPC: F16H35/06
Filed: 2005-09-14
Abstract: A drive gear assembly is disclosed. The assembly includes a drive shaft (11) and a drive gear (9) mounted on or integral with a drive shaft and rotatable therewith and being adapted to mesh with a driven gear (7). The assembly also includes a self-aligning assembly that supports the drive shaft for rotation about an axis of the drive shaft and so that the drive gear can self-align with respect to the driven gear.
Patent CA-2580984-A1 (CA)
Title: Sampler
Inventor: BOERRIGTER PETRUS JACOBUS
IPC: A61B10/00
Filed: 2004-09-23
Abstract: Sampler for self-sampling of samples from a body cavity, such as cervical samples. Optimum accessibility of the cervix is achieved through the sampler comprising a rigid plastic tube which is rounded at the front side. During its introduction, the sampler can accurately be moved to the cervix. The sampler is surrounded by the vagina and can prevent leakage of flushing liquid, and it is possible to use a relatively small quantity of flushing liquid while producing a sample with a high concentration of cervical cells. It is possible to reach the sampling location in a simple and more accurate way which does not damage tissue. As a result of the tube simultaneously being designed as a cylinder for a plunger, it is possible, to flush the desired location with a solution using a cylinder-plunger and, to take the sample by drawing the plunger back.
Patent CA-2582135-A1 (CA)
Title: Fluorescence polarization assay for determining histidine decarboxylase activity
Inventor: AUGUST E MICHAEL
IPC: G01N33/53
Filed: 2005-11-15
Abstract: A fluorescence polarization assay for determining the HDC modulating activity of a candidate compound comprising the steps of: a) providing a reaction mixture comprising a HDC, histidine, a fluorescently labeled histamine probe, a candidate compound and an anti histidine antibody having selectivity for histamine at least 10 fold greater than histidine; b) incubating the reaction mixture; c) determining whether inhibition of HDC has occured in the presence of the test compound, wherein an increase in fluorescence signal is an indication that the test compound inhibits the activity of HDC.
Patent CA-2583757-A1 (CA)
Inventor: GLOVER CHARLES LESLIE
IPC: B07B1/46
Filed: 2005-10-05
Abstract: A sieve frame of the kind generally used in a sifter where a number of such frames are superimposed in a stack, the frame comprising side walls (13) adapted to enclose a loose clothing frame through which the material is sifted, being made from a food-quality plastics material and having male and female interlocking labyrinth seals (20, 21, 22 and 23, 24, 25) at the upper and lower edges to lock the superimposed frames together and to seal against the escape of stock between the frames.
Patent CA-2584282-A1 (CA)
Title: Apparatus and method for manufacturing plastic products
Inventor: HOOGLAND HENDRICUS ANTONIUS
IPC: B29C48/30
Filed: 2005-10-11
Abstract: An injection molding apparatus (100) comprising a supply device (114) for at least partially molten plastic and at least two molds (103) , wherein each mol comprises at least one mold cavity (30) defined by at least a first mold part (24) and a second mold part (25) , while a distributor (104) is provided which carries the first mold parts and connects the mold cavities with the supply device.
Patent CA-2587110-A1 (CA)
Inventor: VOON GERARD
IPC: A61K51/12
Filed: 2007-04-24
Abstract: In addition to the localized multi needles of number, shape, lengths and sizes we could:    1. Perhaps use magnetized particles in the nano shells/or retro virus/ or bis peptides or combination to move a solution/swarm of these particles toward the concentration of the infection or where the infection is most virulent and stubborn and most importantly where it is starting to infect a critical organ, eg. hemorrhagic fever.     2. Use radio active particles to track the position of the swarm/solution (of nano shells or retro viruses or bis peptides or combination) spread/concentration to know when (guesstimate) is best to electrically stimulate.     3. Then when the (i) nano shells or retro viruses or bis peptides or combination are next to or bonded/linked/connected to the protein or other mechanism on the cell membrane of the (ii) antibiotic resistant/or virulent bacteria/virus, we could use electrical stimulus to cause (i) to fuse into (ii).     4. Finally we could create a bis peptide that carries (linked/connected/bonded) on one end to nano shells and/or retro viruses (possibly multiple), and on the other end (amine/carboxyl)s specifically designed to bond/link/connect to the antibiotic resistant or virulent bacteria/virus but not to affect any human cells.     5. We could use epigenetic drugs (molecular switches) such as methylation to turn off the genes (or other organism parts) responsible for the increase in antibiotic resistance and also virulence. Or perhaps acetylation, which might turn on the gene to be antibiotic resistant.  Whichever works. We prefer this treatment because it is less invasive, after our solution/swarm has delivered the epigenetic drugs to take away the antibiotic resistance and or virulence, we can administer less strong versions of antibiotics and end the eternal war to out evolve the ever growing resisrance of bacteria/viruses to resistance.     6. We could design nano shell decoys (to have a similar surface as human cells - study what mechanism the specifically viruses but also bacteria - activate their attack instincts; attracts them to seek and infect human cells). Or retro virus and or nano shells and or bis peptide decoys that either fills up their binding site or when attacked, and or deliver epigenetic drug -a chemical that is lethal (perhaps disabling key survival bacteria/virus parts - that does not necessarily affect the bacteria/viruses outer cell membrane so the chemical does affect the human patient's body) to the antibiotic resistant/virulent bacteria/virus, but this chemical if spills outside the bacteria/virus membrane would be dissolved/dispersed into harmless concentration.
Patent CA-2588513-A1 (CA)
Inventor: CASPER MARTIN
IPC: C07D417/12
Filed: 2005-11-17
Abstract: The present invention relates to certain 3-phenyl-pyrazole derivatives of Formula (Ia) and pharmaceutical compositions thereof that modulate the activity of the 5-HT2A serotonin receptor. Compounds and pharmaceutical compositions thereof are directed to methods useful in the treatment of platelet aggreagation, coronary artery disease, myocardial infarction, transient ischemic attack, angina, stroke, atrial fibrillation, reducing the risk of blood clot formation, asthma or symptoms thereof, agitation or a symptom, behavioral disorders, drug induced psychosis, excitative psychosis, Gilles de la Tourette's syndrome, manic disorder, organic or NOS psychosis, psychotic disorder, psychosis, acute schizophrenia, chronic schizophrenia, NOS  schizophrenia and related disorders, and sleep disorders, sleep disorders, diabetic-related disorders, progressive multifocal leukoencephalopathy and the like. The present invention also relates to the methods for the treatment of 5-HT2A serotonin receptor mediated disorders in combination with other pharmaceutical agents administered separately or together.
Patent CA-2589143-A1 (CA)
Inventor: GRAVAGNE IAN
IPC: A63B24/00
Filed: 2005-12-01
Abstract: A system and method for providing an automatic identification, or a combination of automatic identification and automatic or manual programmed training, for more than one user on at least one exercise machine. The exercise machine is equipped with a user identification device that is in data communication with a system having an identification system and a storage database. The method includes automatically identifying, monitoring and interfacing exercise machine information and database information for at least one user by detecting automatically the presence or absence of a user identification tag and using a default profile or a specific user profile load predetermined difficulty settings or user defined difficulty settings into the programmable exercise machine, which includes resistance or repetition settings.
Patent CA-2593304-A1 (CA)
Title: Means and methods for the differentiation of cardiac and pulmonary causes of acute shortness of breath
Inventor: HESS GEORG
IPC: G01N33/74
Filed: 2007-07-09
Abstract: The present invention relates to a method for differentiating in a subject suffering from acute shortness of breath (dyspnea) between (i) a pulmonary disease, (ii) a cardiovascular complication, (iii) a cardiovascular complication accompanied by a pulmonary disease or (iv) acute dyspnea without cardiovascular or pulmonary causes comprising the steps of determining the amount of SP-B in a sample of a subject, determining the amount of a natriuretic peptide in a sample of said subject, and differentiating between (i) a pulmonary disease, (ii) a cardiovascular complication, (iii) a cardiovascular complication accompanied by a pulmonary disease or (iv) acute dyspnea without cardiovascular or pulmonary causes by comparing the determined amounts with reference amounts. Moreover, the present invention relates to a device and a kit for carrying out said method.
Patent CA-2596476-A1 (CA)
Inventor: WILTON ALISON J
IPC: G01N33/564
Filed: 1997-02-10
Abstract: Human antibodies, preferably recombinant human antibodies, that specifically bind to human tumor necrosis factor a (hTNF.alpha.) are disclosed. These antibodies have high affinity for hTNF.alpha.  (e.g., K d= 10 -8 M or less), a slow off rate for hTNF.alpha. dissociation (e.g., K off =10 -3sec-1 or less) and neutralize hTNF.alpha. activity in vitro and in vivo. An antibody of the invention can be a full--length antibody or an antigen-binding portion thereof. The antibodies, or antibody portions, of the invention are useful for detecting hTNF.alpha. and for inhibiting hTNF.alpha. activity, e.g., in a human subject suffering from a disorder in which hTNF.alpha. activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant human antibodies of the invention, and methods of synthesizing the recombinant human antibodies, are also encompassed by the invention.
Patent CA-2597070-A1 (CA)
Title: Access sampling station
Inventor: DENTON PAYNE S
IPC: E03B7/07
Filed: 2007-07-17
Abstract: " In underground pressurized water systems the sampling of water and the release of air is required. In this invention a hollow structure is partially buried in the ground with a fitting installed at the base. The exterior end of the fitting is connected to the underground water system. Connected to the interior end of this fitting are the sampling controls. These sampling controls can be operated or accessed through top end of the hollow structure. The sampling controls facilitate the sampling or release of the material in the system. The hollow structure and fitting permit the connection/disconnection of sampling controls from the water system and removal from within the hollow structure for repair or replacement."
Patent CA-2597939-A1 (CA)
Title: Dispositif d'alimentation en carburant d'un moteur a turbine a gaz avec debit de carburant regule
Inventor: VARIZAT ALAIN
IPC: F02C9/26
Filed: 2006-02-17
Abstract: Le dispositif d'alimentation en carburant comprend une conduite d'alimentation en carburant (126) recevant du carburant sous pression non régulée fourni par une pompe (100), un dispositif (122) de mesure du débit du carburant dans la conduite (126), une première vanne (124) à ouverture variable commandée montée sur la conduite d'alimentation, un système de commande relié au dispositif de mesure de débit et à la première vanne pour commander celle-ci afin de fournir au moteur un débit de carburant désiré en régime de fonctionnement normal du moteur, une deuxième vanne (134) à  ouverture variable commandée montée sur la conduite d'alimentation en série avec la première, et des moyens de commande de la deuxième vanne permettant de fournir au moteur un débit de carburant réduit ajustable en réponse à une détection de sur-vitesse ou sur-poussée du moteur.
Patent CA-2598129-A1 (CA)
Inventor: CHISHOLM BRET JA
IPC: C09D133/00
Filed: 2006-03-06
Abstract: A composition comprising a phenylthioethylacrylate, a multifunctional (meth)acrylate, a curing agent, wherein the phenylthioethylacrylate comprises less than about 400 parts per million tin and less than about 2 percent by weight of the corresponding phenylthioethanol. The composition may further comprise at least one unsaturated acid.
Patent CA-2599179-A1 (CA)
Inventor: FUJIKAWA SUSUMU
IPC: A45D19/14
Filed: 2007-08-28
Abstract: A washing device for washing a portion of a user's head includes a discharge section which discharges a cleaning liquid into a washing cap attached to a portion of a user's head, and a recovery section which drains the cleaning liquid out of the washing cap so as to recover it. The device again discharges the cleaning liquid recovered by the recovery section from the discharge section, and recirculates the cleaning liquid so as to wash the portion of the user's head covered by the washing cap. When the cleaning liquid is dispersed into the washing cap, the cleaning liquid passes through a nozzle unit so that a lot of microbubbles are generated in the cleaning liquid. The microbubbles are very fine air bubbles, and can remove fine particles of dirt down to the order of a few microns but do not damage the user's scalp and hair.
Patent CA-2603016-A1 (CA)
Inventor: SUGITA MASARU
IPC: A61M15/00
Filed: 2006-03-28
Abstract: The present invention provides a liquid composition, as an ejection liquid used for stably ejecting liquid droplets, including at least one kind of a protein and a peptide, and a compound having a betaine skeleton by application of thermal energy to the liquid; a method of making droplets form the liquid;  and an ejection method and an ejection device suitable for utilizing protein liquid droplets. By adding a compound having a betaine skeleton to an aqueous solution of at least one kind of a protein and a peptide, the liquid composition is improved in stability for ejection by application of thermal energy. Further, a surfactant may be further added to the liquid composition containing the compound having a betaine skeleton, and in this case the effect of stable ejection can be obtained.
Patent CA-2603135-A1 (CA)
Inventor: OUELLETTE NORMAND
IPC: B23D47/02
Filed: 2007-09-18
Abstract: A convertible miter/table saw comprises a base frame supporting a lower, miter saw table rotatable about a vertical axis. A circular saw assembly, namely a saw blade and motor, is mounted on a rear pedestal of the table and pivotable about a horizontal axis, the miter saw table providing a turntable and having a lower saw slot for receiving the saw blade. In miter saw mode, the swivel position of the miter saw table is adjusted and the circular saw blade moved downwards into the lower saw slot.  In table saw mode, an upper saw table connected to the rear of the base frame is pivoted about a horizontal axis from a raised, generally vertical position to a lowered, generally horizontal position in which a slot in the upper saw table accommodates the circular saw blade when the latter is aligned therewith.
Patent CA-2603240-A1 (CA)
Title: Osteosynthetic implants and methods of use and manufacture
Inventor: PACACCIO DOUGLAS J
IPC: A61B17/86
Filed: 2006-04-21
Abstract: Bone fracture fixation devices, systems and methods of use and manufacture are provided. One such bone fixation device includes an elongate element having a responsive zone. The element is adapted to be coupled to the bone so that the responsive zone is positioned adjacent a fracture or fusion site in the bone.  The responsive zone is adapted to apply a desired pressure to the bone when coupled thereto. In some embodiments, the responsive zone comprises a shape memory material, which may be nickel titanium or Nitinol, to apply compressive pressure across the fracture or fusion site for longer periods of time than standard bone screws.
Patent CA-2607394-A1 (CA)
Title: Position sensor
Inventor: SCHAD ROBERT DIETRICH
IPC: B29C45/46
Filed: 2007-10-23
Abstract: A drive assembly for an injection unit of an injection molding machine is provided. The drive assembly includes a motor having a central hollow; and a position sensor, extending at least partially within the central hollow.
Patent CA-2607506-A1 (CA)
Title: Novel lactam compound
Inventor: TAKAYANAGI MASARU
IPC: C07D207/38
Filed: 2006-04-28
Abstract: A novel lactam compound; a glucose transport enhancer comprising the compound as an active ingredient; a prophylactic and/or therapeutic agent for diabetes, diabetic peripheral neuropathy, diabetic nephropathy, diabetic retinopathy, diabetic macroangiopathy, impaired glucose tolerance or obesity; a process for producing the novel lactam compound; an intermediate of the production of the novel lactam compound; and others.
Patent CA-2609665-A1 (CA)
Title: Feline hemoplasma organism having a 16s rrna, methods of detection and isolated nucleic acid
Inventor: WILLI BARBARA
IPC: C12Q1/68
Filed: 2006-05-03
Abstract: A newly identified hemoplasma agent, Candidatus Mycoplasma turicensis, is disclosed. Also disclosed are detection methods, screening methods and methods of diagnosis for the hemoplasma agent.
Patent CA-2611160-A1 (CA)
Inventor: ARJOMANDI FAY
IPC: H04L69/14
Filed: 2006-06-06
Abstract: A method of controlling a mobile device based on a network policy, wherein the network policy is stored on the mobile device when a server or acess point is accessed. When a packet is transmitted, it is sent only if it meets the policy parameters as established by the network policy. Parameters may include the type of service or packet, the time of day of the usage, or the maximum tolerable delay permitted.
Patent CA-2611349-A1 (CA)
Inventor: LI QING
IPC: C07K14/705
Filed: 2006-10-19
Abstract: This invention relates to chimeric taste receptors comprising the extracellular portion of one TlR or a variant or fragment thereof, either TlRl or T1R2, and the transmembrane portion of another TlR or a variant or fragment thereof, either TlRl or T1R2, preferably associated with a T1R3 polypeptide and a suitable G protein. These chimeric taste receptors and cells which express such chimeric taste receptors are useful in assays for identifying sweet and umami ligands as well in assays for identifying sweet and umami enhancers. Additionally, these chimeric taste receptors and cells which express same can be used to map and determine where specific sweet and umami ligands interact with their respective receptors and to elucidate the mechanism of receptor activation.
Patent CA-2612510-A1 (CA)
Title: Tubular fuel cell with electrically conducting spacer and fuel cell module
Inventor: HAMA YUICHIRO
IPC: H01M8/24
Filed: 2006-08-03
Abstract: A tubular fuel cell (100) comprises a cylindrical internal electrode (30) having electrical conductivity, a lamination of a first catalytic layer (32) , an electrolytic layer (34) , and a second catalytic layer (36) laminated in that order on an outer circum-ferential surface of the internal electrode, and an electrically conductive exterior coil (38) wound around an outer circumferential surface of the second catalytic layer. The tubular fuel cell further comprises an electrically conductive spacer (42) which has an outside diameter greater than that of the exterior coil .
Patent CA-2614505-A1 (CA)
Title: Method of using a two-axis gyroscopic
Inventor: EPPLIN M DAVID
IPC: E21B47/022
Filed: 2004-08-06
Abstract: A method of using a two-axis gyroscope on a housing for determining a rate of rotation of the housing about a third axis is provided. The two axes of the two-axis gyroscope are substantially orthogonal to each other, wherein the third axis has a small deviation from orthogonality relative to at least one of the two axis.
Patent CA-2616752-A1 (CA)
Title: Sealing and retaining cable attachment for telecommunications closures
Inventor: BLACKWELL CHOIS ALVEN JR
IPC: G02B6/44
Filed: 2006-07-27
Abstract: There is provided a cable attachment for sealing and retaining cables entering an opening of a telecommunications closure. The cable attachment includes an adapter body with an opening through which the cable passes; and a grip device and grommet device are also located within the opening of the adapter body for strain relieving and sealing, respectively, the cable passing through the adapter body. The cable attachment further includes a bolt portion that is selectively moveable relative to the adapter body for applying a force to the grommet device for selectively creating a seal about an outer surface of the cable. Alternative designs for sealing and/or strain relieving cables entering a closure are provided.
Patent CA-2617796-A1 (CA)
Inventor: STOESSEL VEIT
IPC: B60N2/66
Filed: 2006-08-03
Abstract: The invention relates to a lordosis support which is disposed in a backrest frame of a seat. Said lordosis support comprises a lordosis supporting cage (12) which is arranged in a backrest frame (10) of the seat as well as a pulling device that modifies the position of the lordosis supporting cage (12) relative to the frame. The inventive lordosis support is characterized in that the pulling device is provided with two traction cables (16, 17) which are coupled to the lordosis supporting cage (12) and the frame in such a way that the lordosis supporting frame (12) is moved relative to the plane defined by the backrest frame (10) of the seat when the pulling device is pulled.
Patent CA-2617912-A1 (CA)
Title: Injection laser
Inventor: SHVEYKIN VASILY IVANOVICH
IPC: H01S5/185
Filed: 2006-07-07
Abstract: Injection radiators are used for pumping solid-state and fibre lasers and amplifiers used for producing medical devices, laser production equipment, lasers generating a double-frequency radiation and in the form of highly efficient general-purpose solid-state radiation sources used in a given waveband, including white light emitters used for illumination. Said invention also relates to superpower highly-efficient and reliable injection surface-emitting lasers, which generate radiation in the form of a plurality of output beams and which are characterised by a novel original and efficient method for emitting the radiation through the external surfaces thereof.
Patent CA-2619192-A1 (CA)
Inventor: KASTNER KENNETH P
IPC: D04H3/12
Filed: 2008-01-31
Abstract: A lightweight composite panel exhibiting a high degree of stiffness and strength includes a non-woven fibrous batt comprising more than 50% by weight synthetic fibers, and a geopolymer disposed on and/or within the fibrous batt to impart rigidity to the composite panel. The composite panel may include additional functional and/or aesthetic layers, and may be either flat or contoured. The resulting panels have various architectural, automotive and furniture applications.
Patent CA-2620576-A1 (CA)
Inventor: BEAIR CHARLIE
IPC: F16K17/40
Filed: 2006-08-31
Abstract: A pressure relief device is disclosed for a system containing a pressurized fluid. The device includes a main valve body (12) having inlet (20) and outlet flow (26) ports and a valve plug (52) positioned to seal the flowpath of the pressurized fluid between the inlet port and the outlet port of main valve body. A force transmission component (72) is connected to the valve plug and an activation component (86) is installed between the force transmission component and a mounting surface. The activation component is configured to prevent axial movement of the valve plug until a predetermined pressure is exerted on the valve plug. The force transmission component more efficiently transfers the output force acting on the valve plug to the activation component .